No Image

Approval Triggers Cash Infusion

March 27, 2007 Doug Cress 0

The FDA approval of Antares’ Elestrin resulted in a $1.75 million milestone payment from Bradley Pharmaceuticals. The payment was received pursuant to a marketing agreement Bradley signed […]